If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYellow Cake Regulatory News (YCA)

Share Price Information for Yellow Cake (YCA)

Share Price is delayed by 15 minutes
Get Live Data
538.00    -12.00 (-2.18%)
Bid:
540.00
Ask:
540.50
Spread: 0.50 (0.093%)
Market Cap: £1.36b
YCA Live PriceLast checked at - London Stock Exchange

Intraday Yellow Cake Share Chart

Statement regarding Shareholder Consultation

28 Feb 2025 07:01

RNS Number : 7705Y
Yellow Cake PLC
28 February 2025
 

28 February 2025

Yellow Cake plc ("Yellow Cake" or the "Company")

Statement regarding Shareholder Consultation

 

Yellow Cake, a specialist company operating in the uranium sector holding physical uranium ("U3O8") for the long term, provides an update, in accordance with the UK Corporate Governance Code following its Annual General Meeting held on 3 September 2024 ("AGM").

While all resolutions were passed by a majority of shareholders, Resolution 5 (re-appointment of Sofia Bianchi) and Resolution 11 (an advisory resolution to approve the directors' remuneration report) were passed with the necessary majority but received less than 80% of votes in favour.

At the time of the AGM announcement, the Company noted that Investor Shareholder Services ("ISS"), a proxy advisory firm, recommended that shareholders vote against Sofia Bianchi's re-appointment on 21 August 2024 on the basis of the number of Ms Bianchi's other board positions. On 30 August 2024, following clarification that two of Ms Bianchi's board appointments were within the same shareholder group, ISS recommended that shareholders vote in favour of her re-appointment. Given that the amended ISS recommendation was issued shortly before the proxy voting deadline, there may have been insufficient time for shareholders who follow these recommendations to amend their votes.

ISS also recommended that shareholders vote against the directors' remuneration report, stating that the vesting of Long-Term Incentive Plan ("LTIP") awards was not conditional on the achievement of performance conditions. While the Company did not consider ISS' analysis of the LTIP scheme to be fair or accurate, it undertook to consult with those shareholders who voted against this resolution to better understand their specific concerns.

In light of the feedback received from shareholders and ISS, the Remuneration Committee (the "Committee") has taken the opportunity to review and amend the LTIP with advice from an independent remuneration consultant, to ensure improved alignment with the shareholder experience and expectations (the "Updated LTIP"). The Committee proposes to replace the market-value options with Performance Shares. Performance Shares are a simple and transparent structure and are well-understood by our shareholders and proxy advisors. The Updated LTIP also directly addresses ISS's concerns around performance conditions. The performance conditions have been selected to better align management with investors seeking to participate in an expected increase in the uranium price.

The Company consulted with major shareholders following the LTIP re-design and is therefore confident that the design of this Updated LTIP appropriately rewards management, aligns their interests with those of our shareholders, and ensures that there is no reward for poor performance. The grant of LTIP awards in respect of the financial year ending 31 March 2025 would normally be granted at the start of the financial year, but was deferred pending shareholder consultation. These awards were instead granted on 27 February 2025 and reflect the terms of the Updated LTIP, a summary of which was provided in Yellow Cake's separate regulatory announcement, 'Grant of Awards Under Long Term Incentive Plan', published on 28 February 2025. The new directors' remuneration policy will be fully detailed in the Company's 2025 Annual Report.

The Company will continue to engage with its shareholders on remuneration related matters.

Enquiries:

 

Yellow Cake plc

Andre Liebenberg, CEO

Carole Whittall, CFO

+44 (0) 153 488 5200

Nominated Adviser and Joint Broker:

Canaccord Genuity Limited

James Asensio

Henry Fitzgerald-O'Connor

Charlie Hammond

+ 44 (0) 207 523 8000

Joint Broker: Berenberg

Matthew Armitt

Jennifer Lee

Detlir Elezi

Tel: +44 (0) 203 207 7800

Financial Adviser: Bacchus Capital Advisers

Peter Bacchus

Richard Allan

Tel: +44 (0) 203 848 1640

Communications Adviser: Sodali & Co

Peter Ogden

+44 (0) 779 385 8211

 

 

 

ABOUT YELLOW CAKE

Yellow Cake is a London-quoted company, headquartered in Jersey, which offers exposure to the uranium spot price. This is achieved through its strategy of buying and holding physical triuranium octoxide ("U3O8"). It may also seek to add value through other uranium related activities. Yellow Cake seeks to generate returns for shareholders through the appreciation of the value of its holding of U3O8 and its other uranium related activities in a rising uranium price environment. The business is differentiated from its peers by its ten-year Framework Agreement for the supply of U3O8 with Kazatomprom, the world's largest uranium producer. Yellow Cake currently holds 21.68 million lb of U3O8, all of which is held in storage in Canada and France. 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRTRMFTMTTTBPA
Date   Source Headline
30th Apr 20207:00 amRNSShare Buyback Programme
27th Apr 20207:00 amRNSResponse to U.S. Nuclear Fuel Working Group report
22nd Apr 20207:00 amRNSTransaction in Own Shares
21st Apr 20206:02 pmRNSNotification of Major Shareholdings
20th Apr 20207:00 amRNSQuarterly Operating Update
20th Apr 20207:00 amRNSTransaction in Own Shares
15th Apr 20208:14 amRNSTransaction in Own Shares
14th Apr 20207:00 amRNSTransaction in Own Shares
7th Apr 20207:00 amRNSTransaction in Own Shares
3rd Apr 20207:00 amRNSTransaction in Own Shares
2nd Apr 20207:00 amRNSTransaction in Own Shares
26th Mar 202010:53 amRNSHolding(s) in Company
25th Mar 20207:00 amRNSTransaction in Own Shares
24th Mar 20207:00 amRNSTransaction in Own Shares
23rd Mar 20207:00 amRNSCOVID-19 Update
20th Mar 20207:00 amRNSTransaction in Own Shares
19th Mar 20207:00 amRNSTransaction in Own Shares
13th Mar 20207:00 amRNSTransaction in Own Shares
12th Mar 20207:00 amRNSTransaction in Own Shares
11th Mar 20207:00 amRNSTransaction in Own Shares
10th Mar 20207:00 amRNSTransaction in Own Shares
9th Mar 20207:00 amRNSTransaction in Own Shares
6th Mar 20207:00 amRNSTransaction in Own Shares
5th Mar 20207:00 amRNSTransaction in Own Shares
3rd Mar 20207:00 amRNSTransaction in Own Shares
26th Feb 20207:00 amRNSTransaction in Own Shares
25th Feb 20207:00 amRNSTransaction in Own Shares
24th Feb 20207:00 amRNSTransaction in Own Shares
21st Feb 20202:40 pmRNSDirector Shareholding
20th Feb 20207:00 amRNSTransaction in Own Shares
20th Feb 20207:00 amRNSTransaction in Own Shares
19th Feb 20207:00 amRNSTransaction in Own Shares
17th Feb 20207:00 amRNSTransaction in Own Shares
14th Feb 20207:00 amRNSTransaction in Own Shares
11th Feb 20207:00 amRNSTransaction in Own Shares
3rd Feb 20207:00 amRNSQuarterly Operating Update
28th Jan 20207:00 amRNSShare Buyback Announcement Update
27th Jan 20207:00 amRNSShare Buyback Programme Update Announcement
24th Jan 20202:43 pmRNSNotification of Major Holdings
24th Jan 20207:00 amRNSShare Buyback Programme Update
22nd Jan 20207:00 amRNSShare Buyback Programme
17th Dec 201910:05 amRNSHolding(s) in Company
12th Dec 20197:00 amRNSInterim Financial Report
29th Oct 20197:00 amRNSQuarterly Operating Update
30th Sep 20199:33 amRNSHolding(s) in Company
26th Sep 20194:40 pmRNSHolding(s) in Company
25th Sep 201911:32 amRNSHolding(s) in Company
5th Sep 20192:09 pmRNSInvestor Presentation
22nd Jul 20195:48 pmRNSHolding(s) in Company
22nd Jul 20197:00 amRNSQuarterly Operating Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.